Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2994)
All Articles published online
|
Aug 14, 2005 (publication date) through Nov 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(30): 4655-4660 [PMID: 16094705 DOI: 10.3748/wjg.v11.i30.4655] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i30/4655.htm |
| Number | Citing Articles |
| 1 |
Mónica Enguita-Germán, Puri Fortes. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World Journal of Hepatology 2014; 6(10): 716-737 doi: 10.4254/wjh.v6.i10.716
|
| 2 |
Tanja Nussbaum, Jana Samarin, Volker Ehemann, Michaela Bissinger, Eduard Ryschich, Akmal Khamidjanov, Xiaolei Yu, Norbert Gretz, Peter Schirmacher, Kai Breuhahn. Autocrine insulin‐like growth factor‐II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis†‡. Hepatology 2008; 48(1): 146 doi: 10.1002/hep.22297
|
| 3 |
Deepak Kumar, Manasi Das, Alexis Oberg, Debashis Sahoo, Panyisha Wu, Consuelo Sauceda, Lily Jih, Lesley G. Ellies, Magda T. Langiewicz, Supriya Sen, Nicholas J. G. Webster. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma. Advanced Science 2022; 9(21) doi: 10.1002/advs.202105120
|
| 4 |
Li Wang, Min Yao, Zhizhen Dong, Yun Zhang, Dengfu Yao. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumor Biology 2014; 35(1): 9 doi: 10.1007/s13277-013-1141-0
|
| 5 |
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda, Osama Hegazy. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 2014; 68(1): 50 doi: 10.1016/j.cyto.2014.02.006
|
| 6 |
Aldona Kasprzak, Wojciech Kwasniewski, Agnieszka Adamek, Anna Gozdzicka-Jozefiak. Insulin-like growth factor (IGF) axis in cancerogenesis. Mutation Research/Reviews in Mutation Research 2017; 772: 78 doi: 10.1016/j.mrrev.2016.08.007
|
| 7 |
Shaohui Tang, Yanfang Chen, Shufen Feng, Tingzhuang Yi, Xuyou Liu, Qiang Li, Zhilong Liu, Cuiping Zhu, Jianjun Hu, Xi Yu, Min Wang, Guoli Cao, Hui Tang, Caiqun Bie, Feng Ma, Huijun Tang, Gang Du, Jianwei Huang. MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma. Oncotarget 2017; 8(59): 99871 doi: 10.18632/oncotarget.21737
|
| 8 |
Kai Breuhahn, Peter Schirmacher. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1690-1698 doi: 10.3748/wjg.14.1690
|
| 9 |
Minoru Tomizawa, Hiromitsu Saisho. Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma. World Journal of Gastroenterology 2006; 12(40): 6531-6535 doi: 10.3748/wjg.v12.i40.6531
|
| 10 |
Kurinchi Gurusamy. Trace Element Concentration in Primary Liver Cancers—A Systematic Review. Biological Trace Element Research 2007; 118(3): 191 doi: 10.1007/s12011-007-0008-x
|
| 11 |
Georgios Tzimagiorgis, Evangelia Z. Michailidou, Aristidis Kritis, Anastasios K. Markopoulos, Sofia Kouidou. Recovering circulating extracellular or cell-free RNA from bodily fluids. Cancer Epidemiology 2011; 35(6): 580 doi: 10.1016/j.canep.2011.02.016
|
| 12 |
Hui Zhao, Vidhi Desai, Jian Wang, David M. Epstein, Mark Miglarese, Elizabeth Buck. Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines. Molecular Cancer Therapeutics 2012; 11(2): 503 doi: 10.1158/1535-7163.MCT-11-0327
|
| 13 |
Ya-Wen Chen, Victor Boyartchuk, Brian C. Lewis. Differential Roles of Insulin-like Growth Factor Receptor- and Insulin Receptor-mediated Signaling in the Phenotypes of Hepatocellular Carcinoma Cells. Neoplasia 2009; 11(9): 835 doi: 10.1593/neo.09476
|
| 14 |
Ulrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, Kira Simonsen, Poul Frølund Vestergaard, Jens Otto Lunde Jørgensen, Allan Flyvbjerg, Hendrik Vilstrup, Jan Frystyk. The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment. Growth Hormone & IGF Research 2015; 25(4): 174 doi: 10.1016/j.ghir.2015.05.002
|
| 15 |
K. Breuhahn. Molekulare Progressionsmechanismen der humanen Hepatokarzinogenese. Der Pathologe 2010; 31(S2): 170 doi: 10.1007/s00292-010-1337-7
|
| 16 |
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
|
| 17 |
Diego Francesco Calvisi, Matthias Evert, Frank Dombrowski. Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats. Archives of Physiology and Biochemistry 2009; 115(2): 97 doi: 10.1080/13813450902870457
|
| 18 |
Ghaith Khair, John R. T. Monson, John Greenman. Epithelial Molecular Markers in the Peripheral Blood of Patients with Colorectal Cancer. Diseases of the Colon & Rectum 2007; 50(8): 1188 doi: 10.1007/s10350-006-0875-9
|
| 19 |
Shaohui Tang, Wei Hu, Jianjun Hu, Shenglan Wu, Junfeng Li, Yuhong Luo, Mingrong Cao, Hongke Zhou, Xiangwu Jiang. Hepatitis B virus X protein promotes P3 transcript expression of the insulin‐like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma. Liver International 2015; 35(2): 608 doi: 10.1111/liv.12469
|
| 20 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
|
| 21 |
William C. Chapman, Kevin M. Korenblat, Kathryn J. Fowler, Nael Saad, Adeel S. Khan, Vijay Subramanian, Maria B. Majella Doyle, Leigh Anne Dageforde, Benjamin Tan, Patrick Grierson, Yiing Lin, Min Xu, Elizabeth M. Brunt. Hepatocellular carcinoma: Where are we in 2018?. Current Problems in Surgery 2018; 55(11): 450 doi: 10.1067/j.cpsurg.2018.10.002
|
| 22 |
C. Morace, M. Cucunato, R. Bellerone, G. De Caro, S. Crinò, A. Fortiguerra, F. Spadaro, A. Zirilli, A. Alibrandi, P. Consolo, C. Luigiano, M.L. Resta, O. Ferraù, A. Spadaro. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?. European Journal of Internal Medicine 2012; 23(6): e157 doi: 10.1016/j.ejim.2012.04.014
|
| 23 |
Jing Qian, Dengfu Yao, Zhizhen Dong, Wei Wu, Liwei Qiu, Ninghua Yao, Shanshan Li, Yinzhu Bian, Zhiwei Wang, Gongsheng Shi. Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular Carcinoma. American Journal of Clinical Pathology 2010; 134(5): 799 doi: 10.1309/AJCPTFDSE2V3LCZP
|
| 24 |
Daniel T. Dransfield, Edward H. Cohen, Qing Chang, Lindsay G. Sparrow, John D. Bentley, Olan Dolezal, Xiaowen Xiao, Thomas S. Peat, Janet Newman, Patricia A. Pilling, Tram Phan, Ilka Priebe, Gemma V. Brierley, Niksa Kastrapeli, Kris Kopacz, Diana Martik, Dina Wassaf, Douglas Rank, Greg Conley, Yan Huang, Timothy E. Adams, Leah Cosgrove. A Human Monoclonal Antibody against Insulin-Like Growth Factor-II Blocks the Growth of Human Hepatocellular Carcinoma Cell Lines In vitro and In vivo
. Molecular Cancer Therapeutics 2010; 9(6): 1809 doi: 10.1158/1535-7163.MCT-09-1134
|
| 25 |
H.M. El Tayebi, W. Salah, I.H. El Sayed, A.R.N. Zekri, N. Zayed, E.S. Salem, G. Esmat, A.I. Abdelaziz. Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients. Biomarkers 2011; 16(4): 346 doi: 10.3109/1354750X.2011.573095
|
| 26 |
Franck Chiappini. Circulating Tumor Cells Measurements in Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/684802
|
| 27 |
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth C. Yanek, Robert A. Fisher. Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 2007; 84(10): 1262 doi: 10.1097/01.tp.0000287596.91520.1a
|
| 28 |
Anuradha Budhu, Junfang Ji, Xin Wei Wang. Hepatocellular Carcinoma. 2009; : 131 doi: 10.1007/978-1-60327-376-3_5
|
| 29 |
Deng-Fu Yao, Wei Wu, Min Yao, Li-Wei Qiu, Xin-Hua Wu, Xiao-Qin Su, Li Zou, Deng-Bing Yao, Xian-Yong Meng. Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(31): 4966-4972 doi: 10.3748/wjg.v12.i31.4966
|
| 30 |
Aziza A. Saad, Amany El-Sikaily, Maher A. Kamel, Hany Kassem, Mohamed S. Abdel-Latif. Relationship between Metal Pollution and Gene Expression of Insulin-like Growth Factor II. Journal of Health and Pollution 2018; 8(18) doi: 10.5696/2156-9614-8.18.180608
|
| 31 |
K. Breuhahn, P. Schirmacher. Development, Differentiation and Disease of the Para-Alimentary Tract. Progress in Molecular Biology and Translational Science 2010; 97: 251 doi: 10.1016/B978-0-12-385233-5.00009-X
|
| 32 |
Claudia Pivonello, Maria Cristina De Martino, Mariarosaria Negri, Gaia Cuomo, Federica Cariati, Francesco Izzo, Annamaria Colao, Rosario Pivonello. The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets. Infectious Agents and Cancer 2014; 9(1) doi: 10.1186/1750-9378-9-27
|